Original Article

Evaluation of the Relationship Between Mobile Phone Usage and miRNA-574-5p and miRNA-30C-5p Levels in Thyroid Cancer Patients
  • Zekiye Hasbek
  • Ayça Taş
  • Seyit Ahmet Ertürk
  • Barış Sarıakçalı
  • Özge Ulaş Babacan
  • Gülhan Duman
  • Yavuz Siliğ
Mol Imaging Radionucl Ther 2024; 33: 19-27 DOI: 10.4274/mirt.galenos.2023.04880 PMID:38390734
Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma
  • Aylin Oral
  • Bülent Yazıcı
  • Cenk Eraslan
  • Zeynep Burak
Mol Imaging Radionucl Ther 2018; 27: 99-106 DOI: 10.4274/mirt.37450 PMID:30317832
Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer
  • Seray Saraçoğlu
  • Osman Güven
  • Gündüzalp Buğrahan Babacan
  • Savaş Karyağar
  • Tamer Özülker
  • Sadık Ergür
  • Sevda Sağlampınar Karyağar
Mol Imaging Radionucl Ther 2023; 32: 112-116 DOI: 10.4274/mirt.galenos.2022.05826 PMID:37337764
Red Marrow Absorbed Dose Calculation in Thyroid Cancer Patient Using a Simplified Excel Spreadsheet
  • Rangsee Songprakhon
  • Krisana Roysri
  • Putthiporn Charoenphun
  • Krisanat Chuamsaamarkkee
Mol Imaging Radionucl Ther 2020; 29: 124-131 DOI: 10.4274/mirt.galenos.2020.71473 PMID:33094576

Original Research

Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success?
  • Zekiye Hasbek
  • Bülent Turgut
Mol Imaging Radionucl Ther 2016; 25: 79-84 DOI: 10.4274/mirt.88598 PMID:27277324
The Effect of High Dose Radioiodine Therapy on Formation of Radiation Retinopathy During Thyroid Cancer Treatment
  • Tülay Kaçar Güveli
  • Sezer Özkan
  • Müge Öner Tamam
  • Ercan Uyanık
  • Nurcan Ediz
  • Mehmet Mülazımoğlu
  • Tevfik Özpaçacı
Mol Imaging Radionucl Ther 2014; 23: 84-88 DOI: 10.4274/mirt.33042 PMID:25541931
Effectiveness of Radioiodine Treatment for Toxic Nodular Goiter
  • Hatice Şakı
  • Arzu Cengiz
  • Yakup Yürekli
Mol Imaging Radionucl Ther 2015; 24: 100-104 DOI: 10.4274/mirt.48378 PMID:27529884
Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital
  • Yetunde A. Onimode
  • John E. Ejeh
  • Akintunde T. Orunmuyi
Mol Imaging Radionucl Ther 2016; 25: 128-133 DOI: 10.4274/mirt.13007 PMID:27751975

Review

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
  • Steven M. Larson
  • Joseph R. Osborne
  • Ravinder K. Grewal
  • R. Michael Tuttle
Mol Imaging Radionucl Ther 2017; 26: 80-86 DOI: 10.4274/2017.26.suppl.09 PMID:28117292

Original Articles

The Effect of Radioiodine on the Intima Media Thickness of the Carotid Artery
  • Erdem Sürücü
  • Recep Bekis
  • Tarik Sengöz
  • Yusuf Demir
  • Ahmet Orhan Çelik
  • Özge Orbay
  • Bilge Birlik
  • Özhan Ozdogan
  • Enis Igci
  • Hatice Durak
Mol Imaging Radionucl Ther 2013; 22: 85-89 DOI: 10.4274/Mirt.24119 PMID:24416623

Case Report

Aggressive Disease Course of Papillary Thyroid Carcinoma with Focal Undifferentiated Component: A Case Report
  • Saima Riaz
  • Humayun Bashir
  • Aamna Hassan
  • Sajid Mushtaq
  • Arif Jamshed
  • Ahmad Murtaza
Mol Imaging Radionucl Ther 2016; 25: 134-139 DOI: 10.4274/mirt.38358 PMID:27751976
Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report
  • Yakup Yürekli
  • Arzu Cengiz
  • Engin Güney
Mol Imaging Radionucl Ther 2015; 24: 135-137 DOI: 10.4274/mirt.74046 PMID:27529890